FGF21 and metabolic disease: This change may indicate increased risk for development of metabolic disease or liver injury in women, or it could be the case that decreased baseline FGF21 levels down‐regulate sweet preference in an effort to prevent ongoing excessive fructose consumption and metabolic sequelae.